Kreuz W - Search Results

1

Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children--results of a multicenter studys.

Kurnik K, Kreuz W, Horneff S, Düring C, Schobess R, Bidlingmaier C, Ettingshausen CE, Krümpel A, Bogdanova N, Nowak-Göttl U. Kurnik K, et al. Among authors: kreuz w. Haematologica. 2007 Jul;92(7):982-5. doi: 10.3324/haematol.11161. Haematologica. 2007. PMID: 17606451 Free article.

2

Epidemiology of inhibitors and current treatment strategies.

Kreuz W, Ettingshausen CE, Auerswald G, Saguer IM, Becker S, Funk M, Heller C, Klarmann D, Klingebiel T; GTH PUP Study Group. Kreuz W, et al. Haematologica. 2003 Jun;88(6):EREP04. Haematologica. 2003. PMID: 12826530 Review.

3

Long-term aspects of hemophilia B treatment: part I-role for prophylaxis.

Ettingshausen CE, Kreuz W. Ettingshausen CE, et al. Among authors: kreuz w. Blood Coagul Fibrinolysis. 2004 Jun;15 Suppl 2:S11-3. doi: 10.1097/00001721-200406002-00004. Blood Coagul Fibrinolysis. 2004. PMID: 15322452 Review.

4

Role of von Willebrand factor in immune tolerance induction.

Ettingshausen CE, Kreuz W. Ettingshausen CE, et al. Among authors: kreuz w. Blood Coagul Fibrinolysis. 2005 Apr;16 Suppl 1:S27-31. doi: 10.1097/01.mbc.0000167660.30886.e9. Blood Coagul Fibrinolysis. 2005. PMID: 15849524 Review.

5

Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products.

Kreuz W, Ettingshausen CE, Zyschka A, Oldenburg J, Saguer IM, Ehrenforth S, Klingebiel T. Kreuz W, et al. Semin Thromb Hemost. 2002 Jun;28(3):285-90. doi: 10.1055/s-2002-32664. Semin Thromb Hemost. 2002. PMID: 12098090

6

Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding--successful thrombolysis under heparin therapy.

Ettingshausen CE, Saguer IM, Kreuz W. Ettingshausen CE, et al. Among authors: kreuz w. Eur J Pediatr. 1999 Dec;158 Suppl 3:S180-2. doi: 10.1007/pl00014351. Eur J Pediatr. 1999. PMID: 10650865

7

Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors.

Escuriola Ettingshausen C, Halimeh S, Kurnik K, Schobess R, Wermes C, Junker R, Kreuz W, Pollmann H, Nowak-Göttl U. Escuriola Ettingshausen C, et al. Among authors: kreuz w. Thromb Haemost. 2001 Feb;85(2):218-20. Thromb Haemost. 2001. PMID: 11246535

8

Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variations?

Nowak-Göttl U, Escuriola C, Kurnik K, Schobess R, Horneff S, Kosch A, Kreuz W, Pollmann H. Nowak-Göttl U, et al. Among authors: kreuz w. Hamostaseologie. 2003 Feb;23(1):36-40. Hamostaseologie. 2003. PMID: 12567198

9

Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: A prospective clinical case series.

Ettingshausen CE, Kreuz W. Ettingshausen CE, et al. Among authors: kreuz w. Haemophilia. 2010 Jan;16(1):90-100. doi: 10.1111/j.1365-2516.2009.02116.x. Epub 2009 Oct 29. Haemophilia. 2010. PMID: 19878335

10

Inhibitors in patients with haemophilia A.

Kreuz W, Ettingshausen CE. Kreuz W, et al. Thromb Res. 2014 Nov;134 Suppl 1:S22-6. doi: 10.1016/j.thromres.2013.10.016. Epub 2014 Apr 18. Thromb Res. 2014. PMID: 24745722 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters